OCT-648

N/A

Report date: 2026/01/15 16:21:59

Base Information

Drug NameOCT-648
Drug Alias NameOCT-648OCT648
ClassificationOther
Mechanisms of ActionNUAK family SNF1-like kinase 1 inhibitors
TargetsNUAK family SNF1-like kinase 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOscotec Inc
China Registration ClassN/A

Develop Information

Active CompaniesOscotec Inc
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A